Antiplatelet Therapy Discontinuation and the Risk of Serious Cardiovascular Events after Coronary Stenting: Observations from the CREDO-Kyoto Registry Cohort-2
Hirotoshi Watanabe(Municipal Hirakata City Hospital), Kyohei Yamaji(Kokura Memorial Hospital), Yoshihiro Kato(Hyogo Medical University), Takeshi Aoyama(Hyogo Medical University), Mamoru Hayano(Hyogo Medical University), Jong‐Dae Lee(Kobe City Medical Center General Hospital), Ryuji Nohara, Hirofumi Kambara(Hyogo Medical University), Adnan Kastrati(Deutsches Herzzentrum München), Hisao Ogawa(Kumamoto University Hospital), Akinori Takizawa(Hyogo Medical University), Minoru Horie(Nagahama City Hospital), Satoshi Shizuta(Kyoto University), Ryuichi Hattori(Hyogo Medical University), Mitsuru Abe(Kyoto Medical Center), Takashi Tamura(Japanese Red Cross Society Wakayama Medical Center), Manabu Shirotani(Hyogo Medical University), Junichi Tazaki(Hyogo Medical University), Eiji Shinoda(Hyogo Medical University), Yutaka Furukawa(Kobe City Medical Center General Hospital), Kenji Andò(Kokura Memorial Hospital), Hiroki Shiomi(Kyoto University), Satoru Suwa(Juntendo University Shizuoka Hospital), Moriaki Inoko(Hyogo Medical University), Kazuaki Mitsudo(Kurashiki Central Hospital), Katsuhisa Ishii(Hyogo Medical University), Kazushige Kadota(Kurashiki Central Hospital), Hisayoshi Fujiwara(Hyogo Prefectural Amagasaki General Medical Center), Yoshihisa Nakagawa(Shiga University of Medical Science), Takeshi Morimoto(Hyogo Medical University), Hiroshi Eizawa(Hyogo Medical University), Masahiro Natsuaki(Saga University), Teruki Takeda(Hyogo Medical University), Takeshi Kimura(Municipal Hirakata City Hospital), Shinji Miki(Hyogo Medical University), Masaru Tanaka(Kyushu University), Mamoru Takahashi(Hyogo Medical University), Mitsuo Matsuda(Kishiwada City Hospital), Masakiyo Nobuyoshi(Kurume University), Toru Kita(Hyogo Medical University), Yoshiki Takatsu(Hyogo Prefectural Amagasaki General Medical Center), Tomohisa Tada(Shizuoka General Hospital), Shuichi Hamasaki(Hyogo Medical University), Masayuki Kato(MSD K.K. (Japan)), Osamu Doi(Shizuoka General Hospital)
Cited by 12
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k